Cohen Veterans Bioscience operates as a Public-Private Partnership Cooperative Alliance, organizing a network of partners who each contribute complementary and synergistic data, capabilities, or expertise to support a common roadmap for identifying diagnostic biomarkers, building predictive brain disease models, and developing treatments.
Cohen Veterans Bioscience builds upon endeavors by Orion Bionetworks, a Cambridge, MA-based organization that was founded in July 2012, and whose strategic alliance partners span North America and Europe. Orion Bionetwork’s aim was to apply a cooperative, multidisciplinary approach to many brain disorders, beginning with its flagship program for multiple sclerosis (MS). In 2015, Orion Bionetworks received major funding from Cohen Veterans Foundation to harness its approach for Veterans Brain Health. Cohen Veterans Bioscience focuses on PTS and TBI, with discoveries applicable to the overarching challenge of brain disease.
Learn more via the URL shown in the “Website Address” box above…
Notice: The link provided above connects readers to the full content of the posted document. The URL (internet address) for this link is valid on the posted date; AmacFoundation.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc. or the AMAC Foundation, Inc. Providing linkage to external websites does not constitute endorsement of products or services advertised thereon.